Design,Synthesis, and Anticancer Screening for Repurposed Pyrazolo[3,4-d]pyrimidine Derivatives on Four Mammalian Cancer Cell Lines

The present study reports the synthesis of new purine bioisosteres comprising a pyrazolo[3,4-d]pyrimidine scaffold linked to mono-, di-, and trimethoxy benzylidene moieties through hydrazine linkages. First, in silico docking experiments of the synthesized compounds against Bax, Bcl-2, Caspase-3, Ki67, p21, and p53 were performed in a trial to rationalize the observed cytotoxic activity for the tested compounds. The anticancer activity of these compounds was evaluated in vitro against Caco-2, A549, HT1080, and Hela cell lines. Results revealed that two (5 and 7) of the three synthesized compounds (5, 6, and 7) showed high cytotoxic activity against all tested cell lines with IC₅₀ values in the micro molar concentration. Our in vitro results show that there is no significant apoptotic effect for the treatment with the experimental compounds on the viability of cells against A549 cells. Ki67 expression was found to decrease significantly following the treatment of cells with the most promising candidate: drug 7. The overall results indicate that these pyrazolopyrimidine derivatives possess anticancer activity at varying doses. The suggested mechanism of action involves the inhibition of the proliferation of cancer cells.     

The Physico-Chemical Properties of Glipizide: New Findings

The present work is a concrete example of how physico-chemical studies, if performed in depth, are crucial to understand the behavior of pharmaceutical solids and constitute a solid basis for the control of the reproducibility of the industrial batches. In particular, a deep study of the thermal behavior of glipizide, a hypoglycemic drug, was carried out with the aim of clarifying whether the recognition of its polymorphic forms can really be done on the basis of the endothermic peak that the literature studies attribute to the melting of the compound. A number of analytical techniques were used: thermal techniques (DSC, TGA), X-ray powder diffraction (XRPD), FT-IR spectroscopy and scanning electron microscopy (SEM). Great attention was paid to the experimental design and to the interpretation of the combined results obtained by all these techniques. We proved that the attribution of the endothermic peak shown by glipizide to its melting was actually wrong. The DSC peak is no doubt triggered by a decomposition process that involves gas evolution (cyclohexanamine and carbon dioxide) and formation of 5-methyl-N-[2-(4-sulphamoylphenyl) ethyl] pyrazine-2-carboxamide, which remains as decomposition residue. Thermal treatments properly designed and the combined use of DSC with FT-IR and XRPD led to identifying a new polymorphic form of 5-methyl-N-[2-(4-sulphamoylphenyl) ethyl] pyrazine-2-carboxamide, which is obtained by crystallization from the melt. Hence, our results put into evidence that the check of the polymorphic form of glipizide cannot be based on the temperature values of the DSC peak, since such a peak is due to a decomposition process whose Tonset value is strongly affected by the particle size. Kinetic studies of the decomposition process show the high stability of solid glipizide at room temperature.     

Ruthenium (II) Catalyzed C(sp2)−H Bond Alkenylation of 2-Arylbenzo[d]oxazole and 2-Arylbenzo[d]thiazole with Unactivated Olefins

Functionalization of the bio-relevant heterocycles 2-arylbenzo[d]oxazole and 2-arylbenzo[d]thiazole has been achieved through Ru(II)-catalyzed alkenylation with unactivated olefins leading to selective formation of the mono-alkenylated products. This approach has a broad substrate scope with respect to the coupling partners, affords high yields, and works for gram scale synthesis using a readily available Ru-based catalyst. Mechanistic studies reveal a C−H activation pathway for the dehydrogenative coupling leading to the alkenylation. However, the results of the ESI-MS-guided deuterium kinetic isotope effect studies indicate that the C−H activation stage may not be the rate-determining step of the reaction. The use of a radical scavenging agent such as TEMPO did not show any detrimental effect on the reaction outcome, eliminating the possibility of the involvement of a free-radical pathway.     

Incompatibility networks as models of scale-free small-world graphs

We make a mapping from Sierpinski fractals to a new class of networks, the incompatibility networks, which are scale-free, small-world, disassortative, and maximal planar graphs. Some relevant characteristics of the networks such as degree distribution, clustering coefficient, average path length, and degree correlations are computed analytically and found to be peculiarly rich. The method of network representation can be applied to some real-life systems making it possible to study the complexity of real networked systems within the framework of complex network theory.     

基于模糊概率符号有向图的复杂系统故障诊断

通过分析复杂系统的故障信息传递特性,在符号有向图(SDG)中引入了状态关联概率和模糊信息,并结合面向对象技术提出了一种新的故障描述模型--模糊概率有向图.给出了基于此模型的建模方法和诊断流程.进一步引入消息节点和支路,通过连接各子实体对象的模糊概率SDG模型,构成整个复杂系统的模糊概率SDG系统.该模型能对复杂系统故障诊断中存在的复杂关联关系进行建模与故障诊断.利用该方法建立了某武器平台的故障诊断系统,实验结果表明提出的方法有效且实用.     

离子液体中纤维素的溶解及再生特性

探讨了不同来源纤维素在离子液体1-丁基-3-甲基咪唑氯代盐(［bmim］Cl)中的溶解性能,并采用红外光谱、X-射线衍射及热重分析等手段对木浆纤维素在离子液体［bmim］Cl中溶解和再生前后的结构变化进行了分析。结果表明,未经活化的纤维素可直接溶解于离子液体［bmim］Cl 而不发生其它衍生化反应,原纤维素聚合度越低,溶解越容易。再生纤维素分子量较原纤维素有所降低,结晶状态由纤维素Ⅰ转变为纤维素Ⅱ,再生后纤维素热分解温度降低,热稳定性略有下降。     

一类布线问题求解的判别准则和算法

在已有的判决图的基础上,定义了方向性及导出判决图,找到了一个判断布线问题中的1-嵌入问题是否有解的准则和基于此判别准则的算法,并在此基础上进一步研究了禁用构形,找到了1-嵌入问题有解的另一个判别准则.     

哌啶并[2,3-b]哌嗪类衍生物的设计、合成及其抗血小板聚集活性研究

以2,3-二氨基吡啶和2,3-丁二酮为起始原料,经环化、催化氢化和亲核取代反应合成了10个新型哌啶并[2,3-b]哌嗪类衍生物(3a~3j),其结构经¹H NMR、¹³C NMR和HR-MS确证。体外抗血小板聚集活性研究表明,化合物3d、3e、3g、3h和3j具有一定的抗血小板聚集作用,其中化合物3h(IC₅₀=1.24mmol/L)的活性显著优于母体化合物川芎嗪(IC₅₀=3.96mmol/L)和阳性药物阿司匹林(IC₅₀=2.41mmol/L)。     

通过"双离子键"固载于季鏻盐聚合物的[Rh(CO)I3]2–物种在多相乙醇羰基化中的应用

贵金属物种(Rh或Ir络合物)在均相羰基化和氢甲酰化催化过程得到了广泛的应用,但始终存在分离繁琐等问题,其均相多相化可很大程度上简化分离操作,故一直广受重视.单位点催化剂因其具有可与均相相比拟的较高金属利用率和选择性而成为均相多相化的重要研究方向之一.研究发现,在碘物种存在的情况下用于固载金属物种的配位键容易断裂,进而导致金属物种的流失,而通过离子键固载的[Rh(CO)₂I₂]^–物种更加稳定,比如著名的甲醇羰基化“Acetica^TM”工艺中,[Rh(CO)₂I₂]^–负一价阴离子物种是以离子键的方式固定在带有阳离子骨架的甲基化聚乙烯吡啶树脂上.与甲醇羰基化过程类似的乙醇羰基化过程是生产重要化工中间体丙酸的主要途径之一,但该过程的均相多相化始终存在着稳定性差这一关键问题.为了解决这一问题,基于之前将固载于季鏻盐聚合物的[Rh(CO)I₃]^2–应用于甲醇羰基化的工作,我们将类似的季鏻盐聚合物固载Rh基催化剂Rh-TPISP用于多相乙醇羰基化过程,通过多种表征进一步证明了Rh物种和P物种结构,并提出了“双离子键”模型.P的K边XANES证明了聚合物TPISP的季鏻化阳离子骨架特征.HAADF-STEM测试表明Rh-TPISP中的Rh呈现单位点分散的状态.Rh的XPS和XANES结果证明了Rh-TPISP中Rh物种的价态介于0~+1.通过EXAFS的拟合解析给出了[Rh(CO)I₃]^2–活性中心结构.由于[Rh(CO)₂I₂]^–为经典的羰基化活性中心,为了进一步证明该结构的正确性,我们将Rh-TPISP的EXAFS和IR谱图与标样[PPh3Et]⁺[Rh(CO)₂I₂]^–对比发现:在EXAFS谱图中,Rh-TPISP中的Rh-C峰高低于[PPh3Et]+[Rh(CO)₂I₂]^–的Rh-C峰高,而Rh-TPISP中的Rh-I峰高高于[PPh3Et]+[Rh(CO)₂I₂]^–的Rh-I峰高,这就说明Rh-TPISP中Rh物种的Rh-C配位数小于2,而Rh-I配位数大于2;在IR谱图中,标样[PPh3Et]+[Rh(CO)₂I₂]^–中有两个羰基振动峰,与该物种的两个Rh-C配位键相符,而Rh-TPISP中的只有一个羰基振动峰,说明Rh-C配位数为1.因此,Rh-TPISP催化剂的季鏻盐骨架中的每个P物种带有一个正电荷,每个带有两个负电荷的[Rh(CO)I₃]^2–通过与两个[P]⁺的静电作用进行固载,形成“双离子键”结构.该催化剂在固定床乙醇羰基化过程中表现出优异的羰基化活性、选择性和稳定性.在3.5 MPa、195 oC反应近1000 h后,Rh-TPISP催化剂TOF保持在约350 h–1,丙酰基选择性为95%以上,高出所有文献报道的均相和多相乙醇羰基化活性.其较高的活性主要是因为[Rh(CO)I₃]^2–比传统Rh活性相[Rh(CO)₂I₂]^–具有更强的富电子性,而较高的稳定性主要是由于“双离子键”这种强静电作用比“AceticaTM”工艺中“单离子键”更有利于Rh物种的固载.故Rh-TPISP催化剂中的“双离子键”对其优异的催化性能具有极其重要的作用,对后续多相乙醇羰基化的发展具有重要意义.     

“Golden” Cascade Cyclization to Benzo[c]-Phenanthridines

Herein, we describe a gold-catalyzed cascade cyclization of Boc-protected benzylamines bearing two tethered alkyne moieties in a domino reaction initiated by a 6-endo-dig cyclization. The reaction was screened intensively, and the scope was explored, resulting in nine new Boc-protected dihydrobenzo[c]phenanthridines with yields of up to 98 %; even a π-extension and two bidirectional approaches were successful. Furthermore, thermal cleavage of the Boc group and subsequent oxidation gave substituted benzo[c]phenanthridines in up to quantitative yields. Two bidirectional approaches under the optimized conditions were successful, and the resulting π-extended molecules were tested as organic semiconductors in organic thin-film transistors.